FRI0075 Rheumatoid arthritis patients receiving glucocorticoid exhibits significant bone quality abnormalities, leading to severe bone fragility regardless of bisphosphonate treatment
Rheumatoid arthritis - etiology, pathogenesis and animal models
FRI0075 Rheumatoid arthritis patients receiving glucocorticoid exhibits significant bone quality abnormalities, leading to severe bone fragility regardless of bisphosphonate treatment
PDF